GlassScriptPhysician profile
Stephen Falk
NPI 1639131303
$1,518.81
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $146 · 2021: $132 · 2022: $505.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $341.31 | 2019-2022 | |
| Lupin INC. | $285.28 | 2019-2020 | |
| Pfizer INC. | $249.35 | 2019-2022 | |
| Hologic Sales and Service, LLC | $92.25 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.08 | 2019-2020 | |
| Amgen INC. | $60.05 | 2019-2022 | |
| Astellas Pharma US INC | $48.67 | 2019-2022 | |
| Evofem Biosciences, INC. | $47.13 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $44.62 | 2019-2022 | |
| Avion Pharmaceuticals | $43.14 | 2019-2021 | |
| Covidien LP | $42.79 | 2019-2020 | |
| Duchesnay USA Incorporated | $27.19 | 2019 | |
| Mayne Pharma Commercial LLC | $24.68 | 2022 | |
| Exeltis, USA INC. | $19.35 | 2019 | |
| Amag Pharmaceuticals, INC. | $19.33 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $17.36 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.30 | 2019 | |
| Ascend Therapeutics US, LLC | $16.60 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.70 | 2021 | |
| Coopersurgical, INC. | $14.95 | 2019 | |
| Myovant Sciences INC. | $14.68 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Falk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.